William J. Shea
Chairman, Board of Directors
William J. Shea, Chairman, Board of Directors. Mr. Shea was elected to the Board in 2001 and served as our Acting Chief Financial Officer from February 1, 2010 through March 15, 2011. He has more than 35 years of experience in the financial services industry. Mr. Shea co-founded DLB Capital in October of 2006, a private equity firm, which he left in October of 2007. From 2005 to 2006, he served as Chairman of Royal & Sun Alliance, USA, and oversaw its divestiture from RSA, an insurance company headquartered in the United Kingdom which trades on the London Stock Exchange. From 2001 to 2004, he was Chief Executive Officer of Conseco, Inc. a public financial services firm which he guided through the bankruptcy and restructuring process, and which was subsequently relisted on the New York Stock Exchange. From 1997 to 2001, he oversaw the turnaround of Centennial Technologies, Inc., a public manufacturing company. Mr. Shea formerly served as Vice Chair and Chief Financial Officer of BankBoston, a public financial services company, from 1993 to 1998, and he was the Vice Chairman of Coopers & Lybrand, a national public accounting firm which has since merged with another entity (Price Waterhouse Coopers, “PwC”), from 1990 to 1992. Overall, he spent 19 years with Coopers & Lybrand from 1974 to1992. Mr. Shea is currently on the boards of AIG SunAmerica, a financial services company and Demoulas Super Markets. Mr. Shea currently serves on the Board as well as the Audit Committee for World Gold Trust Services, LLC, the sponsor of the SPDR Gold Trust, GLD.
Mr. Shea also previously served on the boards of Nasdaq OMX BX, Inc., Boston Private Financial Holdings, Inc., the Boston Children’s Hospital and Northeastern University. Mr. Shea’s significant experience in leadership roles with companies in the financial services industry and his extensive contacts in that industry make him well qualified to serve on our Board. In addition, Mr. Shea brings to our Board useful expertise and knowledge from his past and present service in leadership positions with publicly-held companies.
L. Michael Hone
Director and Chief Executive Officer
Mr. Hone was elected to the Board in 2002. Beginning in December 2010, he served as executive vice president and was charged with corporate strategic planning to support the adoption of Caliber I.D.’s technologies into the mainstream continuum of care. In December 2011, he became chief executive officer (CEO). From June 2008 through August 2010, Mr. Hone served as president, CEO, and director of American Aerogel. From 2006 through 2008, he was a consultant for Tempus Partners, a business-consulting firm of which he was the sole owner. From 2001 to 2005, Mr. Hone served as president and chief operating officer of Conseco, Inc. during which time he helped guide this financial services firm through the bankruptcy and restructuring process. He also served as president and CEO of Centennial Technologies, a manufacturer of digital memory that has since been acquired by another entity, and president, CEO, and chairman of PSC, Inc., an Auto ID manufacturer of digital memory. Both were public companies traded on Nasdaq. Mr. Hone is a named inventor or co-inventor on seven patents. He also currently serves as director for Chairman’s View, Inc. (Boston, MA) and as chairman of the board of trustees at the Killington Mountain School (Killington, VT).
Mr. Carty was elected to the Board in 2008 and has served as the chief marketing officer of Caritas Christi Health Care since 2008. From 2006 to 2008, he headed his own marketing consulting firm, MLM Ventures. Mr. Carty has been president of three advertising agencies, including Wheelhouse (Boston, MA) and Hill Holiday (NY, NY), in positions that spanned the period from 1995 to 2006. During this period, he oversaw all global merger and post-merger marketing and communications activities for the combination of Price Waterhouse and Coopers & Lybrand, which formed the world’s largest professional services firm. Prior to that, Mr. Carty served as partner and chief of staff to the chairman of Coopers & Lybrand, and he also served as head of worldwide marketing for the firm. Mr. Carty is a member of the company’s Audit Committee and Nominating and Corporate Governance Committee and chairs the company’s Executive Compensation Committee.
Mr. Cronin was elected to the Board in February 2013. He currently serves as a Principal and Senior Advisor at 510 Capital Management, an investment management company. From 2009 through 2011, he was a Principal at Ocean Gate Capital Management, an investment management company. From 1997 through 2008, Mr. Cronin served in a number of positions including Senior Vice President, Managing Director, Chief Investment Officer, and Senior Managing Director for Putnam Investments, an investment and financial services company. Mr. Cronin has a BA from Wesleyan University and an MA from Boston College. We believe that Mr. Cronin’s years of experience in the financial services industry enable him to be a valuable contributor to our Board.
Ruben King-Shaw, Jr.
Mr. King-Shaw was elected to the Board in December 2010. Since 2004, he has served as the chief executive officer of Mansa Equity Partners, Inc., a private equity and investment advisory firm specializing in supporting the growth of healthcare companies. He currently serves on the Obama administration’s Medicare’s Program Advisory and Oversight Commission, and he has been a member of the executive committee of the board of Steward Health, LLC since November 2010, and the lead director of athenahealth, Inc., a public health services company, since 2004. From 2001 to 2003, Mr. King-Shaw served as chief operating officer and deputy administrator of the Centers for Medicare and Medicaid Service. Prior to his public service, he had 20 years of operating and executive experience in various health-care service organizations. Mr. King-Shaw is a member of the company’s Audit Committee and Executive Compensation Committee and chairs the company’s Nominating and Corporate Governance Committee.
Mr. Maggiotto was elected to the Board in February 2011. In December 2010, he retired as executive vice president and global head of customer and distribution management for Zurich Financial’s General Insurance Business, a position he held since 2006. Prior to joining Zurich, Mr. Maggiotto was a senior executive advisor at Booz Allen Hamilton, chairman of client development for the parent company of Marsh & McLennan Companies, Inc., and a senior partner for PricewaterhouseCoopers. He was also vice chairman for the former Coopers & Lybrand, a managing partner of their New York region, and chairman of their worldwide financial services industry practice. He is on the boards of the Ronald McDonald House of New York, The Weston Playhouse Theatre Company, and the Spenser Foundation. Mr. Maggiotto is a member of the company’s Executive Compensation Committee and Nominating and Corporate Governance Committee and chairs the company’s Audit Committee.
William F. O’Dell
Mr. O’Dell was elected to the Board in May 2014. Mr. O’Dell was Executive Vice President–Sales & Marketing at DUSA Pharmaceuticals, Inc., where he helped lead the company’s reorganization, turnaround and eventual sale to Sun Pharma for $230 million. Prior to this, he held a series of positions of increasing responsibility at West Pharmaceutical Services, Inc., culminating as Vice President of Marketing & Strategic Business Development. In his roles at West, he reorganized, managed and directed all sales, marketing, technical customer service, account services and contract laboratories. His earlier professional experience includes positions as Director of Marketing at ConvaTec, A Bristol-Myers Squibb Company; and as Vice President of Marketing, Medical Division at Acme United Corporation. He is a graduate of Columbia University’s Executive Marketing Management Program. Mr. O’Dell earned a bachelor’s degree from Saint Charles Borromeo Seminary.
Daniel M. Siegel, M.D.
Dr. Siegel was elected to the Board in January 2014. Dr. Siegel is Clinical Professor of Dermatology at SUNY Downstate Medical Center (State University of New York Health Sciences Center at Brooklyn) and is in private practice at Long Island Skin Cancer and Dermatologic Surgery in Smithtown, NY, a division of ProHealthcare. He also is an attending physician at SUNY Downstate Medical Center-University Hospital of Brooklyn and at the Brooklyn Campus of the Veterans Administration New York Harbor Healthcare System, and is on the medical staff at Eastern Long Island Hospital in Greenport, NY. He is a Fellow and Immediate Past President of the American Academy of Dermatology. He holds an M.S. in management and policy from the State University of New York at Stony Brook, an M.D. from Albany Medical College and a B.A. from Rensselaer Polytechnic Institute. Dr. Siegel has also published numerous papers in peer-reviewed journals.
Mr. Stuka was elected to the Board in June 2013. He has served as Managing Member of Osiris Partners, LLC, an investment adviser (“Osiris”), and is a 30 year investment industry veteran. Prior to founding Osiris in 2000, he served as a Managing Director of Longwood Partners LP, managing small cap institutional accounts. From 1995 until 1997, Mr. Stuka served as a Senior Vice President and portfolio manager of the Market Neutral Growth Fund and Mid Cap Growth Funds at State Street Research & Management Company. From 1986 to 1994, he served as General Partner of Stuka Associates, an investment management firm. Mr. Stuka began his career in 1980 as an Analyst at Fidelity Management & Research Company, where he was an analyst for various industries including healthcare, energy, and transportation, and was an assistant portfolio manager on three mutual funds. In 1984, he became the original manager of the Fidelity OTC Fund. Since August 2011, Mr. Stuka has been an Independent & Non-Executive Director of InspireMD, Inc., also serving on their Nominating, Compensation and Audit Committees.